Copyright
©The Author(s) 2025.
World J Gastroenterol. Jun 28, 2025; 31(24): 107661
Published online Jun 28, 2025. doi: 10.3748/wjg.v31.i24.107661
Published online Jun 28, 2025. doi: 10.3748/wjg.v31.i24.107661
NCEP ATP III (2005)[199] | IDF (2005)[22] | |
Criteria required | Three of five criteria below | Central obesity required plus two other required criteria |
Obesity | Waist circumference: > 40 inches (101 cm) in men; > 35 inches (88 cm) in women | Waist circumference based on ethnicity1 |
Insulin resistance-serum glucose | Fasting serum glucose ≥ 100 mg/dL (≥ 5.6 mmol/L); or medical therapy for hyperglycaemia | Fasting serum glucose ≥ 100 mg/dL (≥ 5.6 mmol/L); or medical therapy for hyperglycaemia |
Dyslipidaemia-serum triglycerides | Serum triglyceride level ≥ 150 mg/dL (> 1.7 mmol/L); or medical therapy for dyslipidaemia | Triglyceride level ≥ 150 mg/dL (> 1.7 mmol/L); or medical therapy for dyslipidaemia |
Dyslipidaemia-serum HDL-C | Serum HDL-C: < 40 mg/dL (< 1.03 mmol/L) in men; < 50 mg/dL (< 1.29 mmol/L) in women; or medical therapy for dyslipidaemia | Serum HDL-C: < 40 mg/dL (< 1.03 mmol/L) in men; < 50 mg/dL (< 1.29 mmol/L) in women; medical therapy for dyslipidaemia |
Hypertension | Systolic blood pressure ≥ 130 mmHg; or diastolic blood pressure ≥ 80 mmHg; or medical therapy for hypertension | Systolic blood pressure ≥ 130 mmHg; or diastolic blood pressure ≥ 80 mmHg; or medical therapy for hypertension |
- Citation: Dutt K, Vasudevan A, Hodge A, Nguyen TL, Srinivasan AR. Cardiometabolic diseases in patients with inflammatory bowel disease: An evidence-based review. World J Gastroenterol 2025; 31(24): 107661
- URL: https://www.wjgnet.com/1007-9327/full/v31/i24/107661.htm
- DOI: https://dx.doi.org/10.3748/wjg.v31.i24.107661